Riskpilot← Back to searchSign inGet full accessCSP Ögonvård AB
ABActiveOrg 5592579014Korsholmsvägen 1Medical specialists activities · NACE 8622Est. 20202 employees
Revenue 2025
SEK 3,2M
EBITDA margin
61.4%
+40402% vs 2024
Equity ratio
79.5%
Financial strength
Net profit 2025
SEK 1,6M
+2056% vs 2024
| Revenue | SEK 3,2M | — |
| EBITDA | SEK 1,9M | +40402% |
| Net profit | SEK 1,6M | +2056% |
| Total assets | SEK 2,5M | +365% |
| Equity | SEK 2M | +272% |
| Employees | 2 | — |
Legal name
CSP Ögonvård AB
Org number
5592579014
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
1 juni 2020
Share capital
SEK 25 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva ögonvård, administrativa tjänster inom vård, personaluthyrning samt därmed förenlig verksamhet. Dessutom ska bolaget verka inom utveckling, programmering och marknadsföring av dator-, video-, och mobilspel samt investeringar inom branschen.
Address
Korsholmsvägen 1
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 523 | 396 | −0 | 0 | 3 151 |
| Staff expenses | — | 0 | −0 | −0 | −1 127 |
| EBITDA | 872 | 395 | −5 | −5 | 1 936 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 872 | 395 | −5 | −5 | 1 936 |
| Net financials | — | — | 0 | 81 | 109 |
| Profit before tax | 872 | 395 | −4 | 76 | 2 045 |
| Tax | −187 | −81 | — | — | −400 |
| Net profit | 685 | 314 | −4 | 76 | 1 645 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 027 | 1 136 | 732 | 533 | 2 479 |
| Equity | 710 | 840 | 648 | 529 | 1 971 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 317 | 296 | 84 | 4 | 509 |
| Total debt | 317 | 296 | 84 | 4 | 509 |
EBITDA margin
61.4%
This company
15.8%
Market median
+289% vs market
20212025
Equity ratio
79.5%
This company
38.2%
Market median
+108% vs market
20212025
Return on equity
83.5%
This company
18.4%
Market median
+354% vs market
20212025
Net profit margin
52.2%
This company
8.1%
Market median
+544% vs market
20212025
Asset turnover
1.27×
This company
1.12×
Market median
+13% vs market
20212025
Debt / equity
0.26×
This company
0.62×
Market median
+58% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-06-01 – 2021-08-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2021 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Deputy Board Member | 2020 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CSP Ögonvård AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Eje Lundström | Board of Directors | 0 companies |
| Cigdem Poyraz | Board of Directors | 0 companies |
| Arman Sözen | Deputy Board Member | 0 companies |
| Serkan Poyraz | Deputy Board Member | 0 companies |
| Susanna Karin Helena Heghammar | Deputy Board Member | 0 companies |